2m 2m 2m 2m 2m 2m 2m
Aldeyra Therapeu (ALDX)
NASDAQ
$1.52$0.00 (0.00%)
Price as of Aug 21, 2026 7:57 PM EDT- $91.7MMarket Cap
- -73.84%1-Year Change
- BiotechnologyIndustry
Aldeyra Therapeu (ALDX)
$1.52$0.00 (0.00%)
ALDX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.52 | ||
Change | +$0.02 (+1.33%) | ||
Open | $1.50 | ||
High | $1.59 | ||
Low | $1.48 | ||
Previous Close | $1.50 | ||
Volume | 1,098,866 | ||
30-Day Average Volume | 911,637 | ||
1-Week Change | -2.56% | ||
1-Month Change | -13.14% | ||
1-Year Change | -73.84% | ||
3-Year Change | -79.60% | ||
5-Year Change | -81.69% | ||
Fundamentals | |||
Shares Outstanding | 60.3M | ||
Total Assets | $47.5M | ||
Market Cap | $91.7M | ||
Enterprise Value | $111.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.5M | ||
Free Cash Flow | -$4.6M | ||
EBIT | -$5.5M | ||
EBITDA | -$5.4M | ||
Net Working Capital | $37.7M | ||
EPS | -$0.09 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -17 | ||
PEG | 0 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue